Wedge Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-100,505
| Closed | -$434K | – | 515 |
|
|
2023
Q3 | $434K | Sell |
100,505
-155,058
| -61% | -$670K | 0.01% | 434 |
|
|
2023
Q2 | $1.68M | Buy |
255,563
+236,209
| +1,220% | +$1.56M | 0.03% | 384 |
|
|
2023
Q1 | $131K | Buy |
19,354
+8,350
| +76% | +$56.7K | ﹤0.01% | 421 |
|
|
2022
Q4 | $81K | Buy |
+11,004
| New | +$81K | ﹤0.01% | 415 |
|
|
2022
Q3 | – | Sell |
-11,206
| Closed | -$122K | – | 432 |
|
|
2022
Q2 | $122K | Buy |
11,206
+902
| +9% | +$9.82K | ﹤0.01% | 401 |
|
|
2022
Q1 | $117K | Buy |
+10,304
| New | +$117K | ﹤0.01% | 416 |
|
|
2021
Q1 | – | Sell |
-10,910
| Closed | -$143K | – | 591 |
|
|
2020
Q4 | $143K | Buy |
+10,910
| New | +$143K | ﹤0.01% | 549 |
|